0000899243-18-023787.txt : 20180905
0000899243-18-023787.hdr.sgml : 20180905
20180905060608
ACCESSION NUMBER: 0000899243-18-023787
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180831
FILED AS OF DATE: 20180905
DATE AS OF CHANGE: 20180905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hamel Lawrence G
CENTRAL INDEX KEY: 0001511368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 181053821
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS INC.
STREET 2: 575 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-31
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001511368
Hamel Lawrence G
C/O ACELRX PHARMACEUTICALS, INC.
351 GALVESTON DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
Chief Development Officer
Common Stock
2018-08-31
4
A
0
6876
1.49
A
24371
D
Common Stock
41964
I
By the Hamel Revocable Living Trust
These shares were acquired under the Company's Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Non-reportable acquisition of 1,116 shares of common stock through the Company's Employee Stock Purchase Plan.
/a/ Martha Adler, Attorney-In-Fact
2018-09-05